Anastasia Budinskaya brings broad experience as an entrepreneur, operator, and investor to the NFX Bio team. Before joining NFX, Anastasia was a Senior Manager of Operations & Strategy at One Mind Accelerator, where she focused on investing in innovative mental health companies. She also served as a Venture Associate at Gilde Healthcare Partners, where she was part of a small team overseeing the US MedTech investment portfolio.

Prior to her transition into venture capital, she was acquihired by GE Healthcare as a Scientific Leader in Neurology. In this role, she designed clinical studies and led technology transfer for the in-licensing of Altropane into GE's Pharmaceutical Diagnostics portfolio from the startup LikeMinds. At LikeMinds, Anastasia led Corporate and Clinical Development under the CEO and CMO and contributed significantly to the out-licensing of Altropane.

She holds an M.S. in Bioengineering, Biomechanical Systems and Devices from Tufts University, and a B.S. in Bioengineering from Syracuse University.